Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$1.57B |
| 2 |
NextEra Energy, Inc.
NEE
|
$1.54B |
| 3 |
RTX Corp
RTX
|
$1.46B |
| 4 |
Air Products & Chemicals
APD
|
$1.19B |
| 5 |
Microsoft
MSFT
|
$1.18B |
Top Sells
| 1 |
Starbucks
SBUX
|
$2.38B |
| 2 |
Netflix
NFLX
|
$1.87B |
| 3 |
Comcast
CMCSA
|
$1.55B |
| 4 |
Baker Hughes
BKR
|
$1.21B |
| 5 |
Amazon
AMZN
|
$1.12B |
Sector Composition
| 1 | Technology | 26.58% |
| 2 | Healthcare | 16.23% |
| 3 | Industrials | 12.73% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Financials | 7.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
426
Sempra
SRE
$53.9B
| – | – | -689,844 | Closed | -$46.9M |
|
427
Sarepta Therapeutics
SRPT
$1.78B
| – | – | -557,461 | Closed | -$67.6M |
|
428
StoneCo
STNE
$4.41B
| – | – | -1,023,331 | Closed | -$10.9M |
|
|
NBIS
429
Nebius Group N.V. Class A Ordinary Shares
NBIS
$16.3B
| – | – | -2,411,420 | Closed | -$26.4M |
|